Published in J Psychiatry Neurosci on November 01, 2008
Effects of lithium on oxidative stress parameters in healthy subjects. Mol Med Rep (2011) 1.05
Quality of Life and Psychiatric Symptoms in Wilson's Disease: the Relevance of Bipolar Disorders. Clin Pract Epidemiol Ment Health (2012) 0.97
Bipolar disorders and Wilson's disease. BMC Psychiatry (2012) 0.83
Abstinence from repeated amphetamine treatment induces depressive-like behaviors and oxidative damage in rat brain. Psychopharmacology (Berl) (2013) 0.81
DNA Damage and Pulmonary Hypertension. Int J Mol Sci (2016) 0.81
Differences between dextroamphetamine and methamphetamine: behavioral changes and oxidative damage in brain of Wistar rats. J Neural Transm (Vienna) (2011) 0.78
Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches. Oxid Med Cell Longev (2016) 0.76
Early life stress exacerbates cognitive dysfunction induced by d-amphetamine: amelioration by valproic acid. J Neural Transm (Vienna) (2012) 0.75
Modafinil effects on behavior and oxidative damage parameters in brain of wistar rats. Behav Neurol (2014) 0.75
Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges. Front Cell Neurosci (2017) 0.75
DNA Damage in Major Psychiatric Diseases. Neurotox Res (2016) 0.75
Amphetamines promote mitochondrial dysfunction and DNA damage in pulmonary hypertension. JCI Insight (2017) 0.75
Oxidative stress in older patients with bipolar disorder. Am J Geriatr Psychiatry (2014) 0.75
Neurobehavioral effects of vigabatrin and its ability to induce DNA damage in brain cells after acute treatment in rats. Psychopharmacology (Berl) (2016) 0.75
Effects of a gastrin-releasing peptide receptor antagonist on D-amphetamine-induced oxidative stress in the rat brain. J Neural Transm (Vienna) (2010) 0.75
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03
Catalase in vitro. Methods Enzymol (1984) 27.79
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem (2001) 6.85
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J (2001) 6.85
Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen (2000) 6.24
Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci (2004) 5.37
Mechanisms of lipid peroxide formation in animal tissues. Biochem J (1966) 3.95
Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging (2001) 3.36
Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord (2002) 3.28
Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry (2006) 2.85
Bipolar disorder. N Engl J Med (2004) 2.75
Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry (2004) 2.27
Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry (2000) 2.21
Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem (1999) 1.77
Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J Neurochem (1999) 1.74
Valproic acid alters chromatin structure by regulation of chromatin modulation proteins. Cancer Res (2005) 1.65
Cytokinesis-block micronucleus method in human lymphocytes: effect of in vivo ageing and low dose X-irradiation. Mutat Res (1986) 1.64
Comet assay in human biomonitoring studies: reliability, validation, and applications. Environ Mol Mutagen (1997) 1.62
Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) (2001) 1.60
The HUman MicroNucleus Project--An international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat Res (1999) 1.60
Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J Neurochem (2002) 1.55
Lithium neuroprotection: molecular mechanisms and clinical implications. Expert Rev Mol Med (2004) 1.44
Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation, oxidative stress and oligodendrocyte viability. Schizophr Res (2006) 1.44
Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochem Res (2001) 1.42
Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord (2002) 1.41
Assays for superoxide dismutase. Methods Biochem Anal (1987) 1.32
Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science (1989) 1.24
Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J Clin Psychiatry (2000) 1.18
Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res (2006) 1.17
Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration. Eur J Pharmacol (2000) 1.13
Mechanisms of oxidant injury of cells. Mol Aspects Med (1991) 1.12
Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am J Psychiatry (2000) 1.12
Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci (2006) 1.11
Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol Psychiatry (2005) 1.08
Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.04
Dextroamphetamine-induced arousal in human subjects as a model for mania. Psychol Med (1986) 0.97
DNA damage in bipolar disorder. Psychiatry Res (2007) 0.96
Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disord (2006) 0.94
Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cells. FEBS Lett (2005) 0.94
Neurochemical similarities between d,l-cathinone and d-amphetamine. Drug Alcohol Depend (1982) 0.91
Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania. Neurochem Res (2006) 0.90
The role of mitochondrial dysfunction in bipolar disorder. Drug News Perspect (2006) 0.87
Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Res (2006) 0.86
Prevention and treatment of Alzheimer disease and aging: antioxidants. Mini Rev Med Chem (2007) 0.86
Repeated amphetamine treatment causes a persistent elevation of glial fibrillary acidic protein in the caudate-putamen. Eur J Pharmacol (2004) 0.86
Effects of setting on the subjective and behavioral effects of d-amphetamine in humans. Addict Behav (1992) 0.82
Role of nitric oxide in cerebral blood flow changes during kainate seizures in mice: genetic and pharmacological approaches. Neurobiol Dis (2005) 0.81
Mood stabilizers: protecting the mood...protecting the brain. J Affect Disord (2004) 0.81
Effects of a chronic lithium treatment on central dopamine neurotransporters. Biochem Pharmacol (1997) 0.80
Oxidative stress detection: what for? Part I. Eur Rev Med Pharmacol Sci (2007) 0.77
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord (2012) 3.01
Cognitive impairment in sepsis survivors from cecal ligation and perforation. Crit Care Med (2005) 2.25
Occupational risk assessment of oxidative stress and genotoxicity in workers exposed to paints during a working week. Int J Occup Med Environ Health (2011) 2.06
Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.78
Mitochondrial dysfunction and psychiatric disorders. Neurochem Res (2008) 1.73
Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res (2011) 1.71
Time-dependent behavioral recovery after sepsis in rats. Intensive Care Med (2008) 1.65
Protective effect of N-acetylcysteine and deferoxamine on carbon tetrachloride-induced acute hepatic failure in rats. Crit Care Med (2004) 1.54
Antioxidant treatment prevented late memory impairment in an animal model of sepsis. Crit Care Med (2007) 1.50
Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord (2008) 1.46
The impact of a history of psychotic symptoms on cognitive function in euthymic bipolar patients: a comparison with schizophrenic patients and healthy controls. Rev Bras Psiquiatr (2011) 1.46
Lithium and tamoxifen modulate cellular plasticity cascades in animal model of mania. J Psychopharmacol (2012) 1.44
Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry (2013) 1.43
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology (2011) 1.41
Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev (2007) 1.36
Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett (2007) 1.35
Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett (2006) 1.34
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord (2009) 1.32
What histone code for DNA repair? Mutat Res (2008) 1.31
Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.28
Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother (2009) 1.26
Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behav Brain Res (2011) 1.24
Antioxidant activity of the flavonoid hesperidin in chemical and biological systems. J Agric Food Chem (2005) 1.23
Low-level laser therapy (LLLT) in human progressive-intensity running: effects on exercise performance, skeletal muscle status, and oxidative stress. Lasers Med Sci (2011) 1.19
The role of hippocampus in the pathophysiology of bipolar disorder. Behav Pharmacol (2007) 1.19
Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLoS Pathog (2010) 1.18
Oxidative stress and hematologic and biochemical parameters in individuals with Down syndrome. Mayo Clin Proc (2005) 1.17
Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res (2006) 1.17
Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol Psychiatry (2006) 1.16
Low level laser therapy before eccentric exercise reduces muscle damage markers in humans. Eur J Appl Physiol (2010) 1.16
Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis. J Clin Psychiatry (2008) 1.14
Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochem Int (2009) 1.13
Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry (2013) 1.12
Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci (2006) 1.11
Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res (2010) 1.10
[Performance of the Self-Reporting Questionnaire as a psychiatric screening questionnaire: a comparative study with Structured Clinical Interview for DSM-IV-TR]. Cad Saude Publica (2008) 1.09
Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev Neurother (2008) 1.09
Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder. Neuropsychopharmacology (2009) 1.09
Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.08
Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci (2006) 1.08
S100B protein and amniotic fluid. Clin Chim Acta (2003) 1.08
Effects of lithium on oxidative stress parameters in healthy subjects. Mol Med Rep (2011) 1.05
Perspectives for the development of animal models of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2004) 1.04
Oxidative variables in the rat brain after sepsis induced by cecal ligation and perforation. Crit Care Med (2006) 1.04
Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.04
Mediators of allostasis and systemic toxicity in bipolar disorder. Physiol Behav (2011) 1.03
Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Rev Bras Psiquiatr (2011) 1.03
A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. J Clin Psychiatry (2008) 1.02
Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression. Neurochem Int (2008) 1.02
The serum S100B concentration is age dependent. Clin Chem (2002) 1.01
Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology. Bipolar Disord (2007) 1.01
Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder. Oxid Med Cell Longev (2012) 1.01
Chemical characterization, antioxidant and cytotoxic activities of Brazilian red propolis. Food Chem Toxicol (2012) 1.00
Production of Pleurotus sajor-caju strain PS-2001 biomass in submerged culture. J Ind Microbiol Biotechnol (2008) 0.99
Inflammation biomarkers and delirium in critically ill patients. Crit Care (2014) 0.98
Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neurosci Lett (2007) 0.98
Il1-β involvement in cognitive impairment after sepsis. Mol Neurobiol (2013) 0.97
Changes in cortical thickness across the lifespan in major depressive disorder. Psychiatry Res (2013) 0.97
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor. Eur J Pharmacol (2012) 0.97
Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm. J Psychiatr Res (2008) 0.97
The rapid effects of estrogen: a mini-review. Behav Pharmacol (2010) 0.97
3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci (2009) 0.97
Effects of gabapentin on anxiety induced by simulated public speaking. J Psychopharmacol (2003) 0.96
DNA damage in bipolar disorder. Psychiatry Res (2007) 0.96
Brain-derived neurotrophic factor and neuron-specific enolase, but not S100β, levels are associated to the occurrence of delirium in intensive care unit patients. J Crit Care (2010) 0.96
Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. J Clin Psychiatry (2010) 0.95
Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus. Oxid Med Cell Longev (2010) 0.95
Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.95
Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disord (2006) 0.94
Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res (2009) 0.94